Location History:
- Cambridge, GB (2001)
- Palo Alto, CA (US) (1999 - 2010)
Company Filing History:
Years Active: 1999-2010
Title: Innovations of Timothy Piers Clackson
Introduction
Timothy Piers Clackson is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing members of specific binding pairs. With a total of nine patents to his name, Clackson's work has advanced the understanding and application of genetic diversity in binding pair members.
Latest Patents
Clackson's latest patents focus on innovative methods for identifying and producing members of specific binding pairs. One of his patents describes a process where DNA encoding a genetically diverse population of specific binding pair members is expressed in recombinant host cells. These members are displayed in functional form on the surface of a filamentous bacteriophage particle. The binding domain of these members consists of a dAb fragment, allowing for selection by affinity with complementary binding pair members. Another patent outlines a similar method using a secreted recombinant genetic display package, where the binding members are expressed as a fusion with a capsid component. This approach enables the recovery of DNA from selected packages for further expression of the binding pair members.
Career Highlights
Throughout his career, Clackson has worked with esteemed organizations such as the Medical Research Council and MedImmune Limited. His experience in these institutions has contributed to his expertise in the field of biotechnology and patent development.
Collaborations
Clackson has collaborated with notable individuals in his field, including John Gerald McCafferty and Anthony Richard Pope. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Timothy Piers Clackson's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His innovative methods for producing specific binding pairs continue to influence research and applications in biotechnology.